nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—Skin disorder—Brinzolamide—glaucoma	0.000778	0.00115	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000777	0.00115	CcSEcCtD
Gemcitabine—Anorexia—Dorzolamide—glaucoma	0.000776	0.00115	CcSEcCtD
Gemcitabine—Arrhythmia—Clonidine—glaucoma	0.000773	0.00115	CcSEcCtD
Gemcitabine—Decreased appetite—Acetazolamide—glaucoma	0.000772	0.00115	CcSEcCtD
Gemcitabine—Insomnia—Brimonidine—glaucoma	0.000771	0.00114	CcSEcCtD
Gemcitabine—Oedema—Pilocarpine—glaucoma	0.000769	0.00114	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000767	0.00114	CcSEcCtD
Gemcitabine—Fatigue—Acetazolamide—glaucoma	0.000766	0.00114	CcSEcCtD
Gemcitabine—Paraesthesia—Brimonidine—glaucoma	0.000766	0.00114	CcSEcCtD
Gemcitabine—Infection—Pilocarpine—glaucoma	0.000764	0.00113	CcSEcCtD
Gemcitabine—Alopecia—Clonidine—glaucoma	0.000764	0.00113	CcSEcCtD
Gemcitabine—Nausea—Methazolamide—glaucoma	0.000762	0.00113	CcSEcCtD
Gemcitabine—Hypotension—Dorzolamide—glaucoma	0.000761	0.00113	CcSEcCtD
Gemcitabine—Dyspnoea—Brimonidine—glaucoma	0.00076	0.00113	CcSEcCtD
Gemcitabine—Somnolence—Brimonidine—glaucoma	0.000758	0.00113	CcSEcCtD
Gemcitabine—Hypotension—Travoprost—glaucoma	0.000758	0.00112	CcSEcCtD
Gemcitabine—Bronchospasm—Timolol—glaucoma	0.000756	0.00112	CcSEcCtD
Gemcitabine—Rhinitis—Betaxolol—glaucoma	0.000755	0.00112	CcSEcCtD
Gemcitabine—Thrombocytopenia—Pilocarpine—glaucoma	0.000753	0.00112	CcSEcCtD
Gemcitabine—Erythema—Clonidine—glaucoma	0.000753	0.00112	CcSEcCtD
Gemcitabine—Hypotension—Brinzolamide—glaucoma	0.000748	0.00111	CcSEcCtD
Gemcitabine—Pharyngitis—Betaxolol—glaucoma	0.000747	0.00111	CcSEcCtD
Gemcitabine—Hyperhidrosis—Pilocarpine—glaucoma	0.000744	0.0011	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000742	0.0011	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Travoprost—glaucoma	0.000739	0.0011	CcSEcCtD
Gemcitabine—Insomnia—Dorzolamide—glaucoma	0.000737	0.00109	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Brimonidine—glaucoma	0.000736	0.00109	CcSEcCtD
Gemcitabine—Fatigue—Brimonidine—glaucoma	0.000735	0.00109	CcSEcCtD
Gemcitabine—Anorexia—Pilocarpine—glaucoma	0.000733	0.00109	CcSEcCtD
Gemcitabine—Feeling abnormal—Acetazolamide—glaucoma	0.000732	0.00109	CcSEcCtD
Gemcitabine—Paraesthesia—Dorzolamide—glaucoma	0.000731	0.00109	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000729	0.00108	CcSEcCtD
Gemcitabine—Pain—Brimonidine—glaucoma	0.000729	0.00108	CcSEcCtD
Gemcitabine—Dyspnoea—Dorzolamide—glaucoma	0.000726	0.00108	CcSEcCtD
Gemcitabine—Insomnia—Brinzolamide—glaucoma	0.000724	0.00107	CcSEcCtD
Gemcitabine—Somnolence—Dorzolamide—glaucoma	0.000724	0.00107	CcSEcCtD
Gemcitabine—Dyspnoea—Travoprost—glaucoma	0.000723	0.00107	CcSEcCtD
Gemcitabine—Hypotension—Pilocarpine—glaucoma	0.000719	0.00107	CcSEcCtD
Gemcitabine—Paraesthesia—Brinzolamide—glaucoma	0.000719	0.00107	CcSEcCtD
Gemcitabine—Dyspnoea—Brinzolamide—glaucoma	0.000714	0.00106	CcSEcCtD
Gemcitabine—Asthenia—Apraclonidine—glaucoma	0.000713	0.00106	CcSEcCtD
Gemcitabine—Somnolence—Brinzolamide—glaucoma	0.000712	0.00106	CcSEcCtD
Gemcitabine—Decreased appetite—Dorzolamide—glaucoma	0.000708	0.00105	CcSEcCtD
Gemcitabine—Pruritus—Apraclonidine—glaucoma	0.000703	0.00104	CcSEcCtD
Gemcitabine—Body temperature increased—Acetazolamide—glaucoma	0.000702	0.00104	CcSEcCtD
Gemcitabine—Fatigue—Dorzolamide—glaucoma	0.000702	0.00104	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000701	0.00104	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Travoprost—glaucoma	0.0007	0.00104	CcSEcCtD
Gemcitabine—Fatigue—Travoprost—glaucoma	0.000699	0.00104	CcSEcCtD
Gemcitabine—Cardiac disorder—Betaxolol—glaucoma	0.000699	0.00104	CcSEcCtD
Gemcitabine—Ill-defined disorder—Clonidine—glaucoma	0.000699	0.00104	CcSEcCtD
Gemcitabine—Pain—Dorzolamide—glaucoma	0.000696	0.00103	CcSEcCtD
Gemcitabine—Insomnia—Pilocarpine—glaucoma	0.000696	0.00103	CcSEcCtD
Gemcitabine—Decreased appetite—Brinzolamide—glaucoma	0.000696	0.00103	CcSEcCtD
Gemcitabine—Constipation—Travoprost—glaucoma	0.000693	0.00103	CcSEcCtD
Gemcitabine—Pain—Travoprost—glaucoma	0.000693	0.00103	CcSEcCtD
Gemcitabine—Hyperglycaemia—Timolol—glaucoma	0.000693	0.00103	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000691	0.00103	CcSEcCtD
Gemcitabine—Paraesthesia—Pilocarpine—glaucoma	0.000691	0.00103	CcSEcCtD
Gemcitabine—Asthenia—Bimatoprost—glaucoma	0.000691	0.00103	CcSEcCtD
Gemcitabine—Fatigue—Brinzolamide—glaucoma	0.00069	0.00102	CcSEcCtD
Gemcitabine—Dyspnoea—Pilocarpine—glaucoma	0.000686	0.00102	CcSEcCtD
Gemcitabine—Pain—Brinzolamide—glaucoma	0.000685	0.00102	CcSEcCtD
Gemcitabine—Somnolence—Pilocarpine—glaucoma	0.000684	0.00102	CcSEcCtD
Gemcitabine—Angiopathy—Betaxolol—glaucoma	0.000683	0.00101	CcSEcCtD
Gemcitabine—Pruritus—Bimatoprost—glaucoma	0.000681	0.00101	CcSEcCtD
Gemcitabine—Immune system disorder—Betaxolol—glaucoma	0.00068	0.00101	CcSEcCtD
Gemcitabine—Diarrhoea—Apraclonidine—glaucoma	0.00068	0.00101	CcSEcCtD
Gemcitabine—Malaise—Clonidine—glaucoma	0.000679	0.00101	CcSEcCtD
Gemcitabine—Mediastinal disorder—Betaxolol—glaucoma	0.000679	0.00101	CcSEcCtD
Gemcitabine—Chills—Betaxolol—glaucoma	0.000676	0.001	CcSEcCtD
Gemcitabine—Arrhythmia—Betaxolol—glaucoma	0.000673	0.000999	CcSEcCtD
Gemcitabine—Feeling abnormal—Dorzolamide—glaucoma	0.000671	0.000996	CcSEcCtD
Gemcitabine—Decreased appetite—Pilocarpine—glaucoma	0.000669	0.000993	CcSEcCtD
Gemcitabine—Feeling abnormal—Travoprost—glaucoma	0.000668	0.000992	CcSEcCtD
Gemcitabine—Alopecia—Betaxolol—glaucoma	0.000665	0.000988	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000664	0.000986	CcSEcCtD
Gemcitabine—Feeling abnormal—Brinzolamide—glaucoma	0.00066	0.000979	CcSEcCtD
Gemcitabine—Pain—Pilocarpine—glaucoma	0.000658	0.000977	CcSEcCtD
Gemcitabine—Constipation—Pilocarpine—glaucoma	0.000658	0.000977	CcSEcCtD
Gemcitabine—Cough—Clonidine—glaucoma	0.000657	0.000975	CcSEcCtD
Gemcitabine—Sweating—Timolol—glaucoma	0.000657	0.000975	CcSEcCtD
Gemcitabine—Erythema—Betaxolol—glaucoma	0.000655	0.000973	CcSEcCtD
Gemcitabine—Body temperature increased—Dorzolamide—glaucoma	0.000644	0.000956	CcSEcCtD
Gemcitabine—Chest pain—Clonidine—glaucoma	0.000641	0.000952	CcSEcCtD
Gemcitabine—Arthralgia—Clonidine—glaucoma	0.000641	0.000952	CcSEcCtD
Gemcitabine—Agranulocytosis—Timolol—glaucoma	0.000639	0.000949	CcSEcCtD
Gemcitabine—Asthenia—Acetazolamide—glaucoma	0.000637	0.000946	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000637	0.000945	CcSEcCtD
Gemcitabine—Feeling abnormal—Pilocarpine—glaucoma	0.000634	0.000941	CcSEcCtD
Gemcitabine—Discomfort—Clonidine—glaucoma	0.000633	0.00094	CcSEcCtD
Gemcitabine—Vomiting—Apraclonidine—glaucoma	0.000631	0.000937	CcSEcCtD
Gemcitabine—Dermatitis—Apraclonidine—glaucoma	0.000626	0.000929	CcSEcCtD
Gemcitabine—Headache—Apraclonidine—glaucoma	0.000622	0.000924	CcSEcCtD
Gemcitabine—Rhinitis—Timolol—glaucoma	0.000617	0.000915	CcSEcCtD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.000616	0.00189	CbGpPWpGaD
Gemcitabine—Oedema—Clonidine—glaucoma	0.000614	0.000912	CcSEcCtD
Gemcitabine—Asthenia—Brimonidine—glaucoma	0.000612	0.000908	CcSEcCtD
Gemcitabine—Infection—Clonidine—glaucoma	0.00061	0.000906	CcSEcCtD
Gemcitabine—Body temperature increased—Pilocarpine—glaucoma	0.000608	0.000903	CcSEcCtD
Gemcitabine—Ill-defined disorder—Betaxolol—glaucoma	0.000608	0.000903	CcSEcCtD
Gemcitabine—Diarrhoea—Acetazolamide—glaucoma	0.000608	0.000902	CcSEcCtD
Gemcitabine—Rash—Bimatoprost—glaucoma	0.000607	0.000901	CcSEcCtD
Gemcitabine—Dermatitis—Bimatoprost—glaucoma	0.000607	0.0009	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RAB8A—glaucoma	0.000606	0.00186	CbGpPWpGaD
Gemcitabine—Oedema peripheral—Timolol—glaucoma	0.000606	0.0009	CcSEcCtD
Gemcitabine—Anaemia—Betaxolol—glaucoma	0.000606	0.000899	CcSEcCtD
Gemcitabine—CDA—Metabolism—CA1—glaucoma	0.000606	0.00186	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000605	0.00186	CbGpPWpGaD
Gemcitabine—Connective tissue disorder—Timolol—glaucoma	0.000604	0.000897	CcSEcCtD
Gemcitabine—Pruritus—Brimonidine—glaucoma	0.000603	0.000896	CcSEcCtD
Gemcitabine—Headache—Bimatoprost—glaucoma	0.000603	0.000896	CcSEcCtD
Gemcitabine—Nervous system disorder—Clonidine—glaucoma	0.000603	0.000895	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000602	0.00185	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—FGFR1OP—glaucoma	0.000602	0.00184	CbGpPWpGaD
Gemcitabine—Thrombocytopenia—Clonidine—glaucoma	0.000602	0.000893	CcSEcCtD
Gemcitabine—Skin disorder—Clonidine—glaucoma	0.000597	0.000886	CcSEcCtD
Gemcitabine—POLD1—Synthesis of DNA—CDKN1B—glaucoma	0.000595	0.00182	CbGpPWpGaD
Gemcitabine—Hyperhidrosis—Clonidine—glaucoma	0.000594	0.000882	CcSEcCtD
Gemcitabine—Malaise—Betaxolol—glaucoma	0.000591	0.000878	CcSEcCtD
Gemcitabine—Nausea—Apraclonidine—glaucoma	0.00059	0.000876	CcSEcCtD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2B—glaucoma	0.00059	0.00181	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CTSA—glaucoma	0.000587	0.0018	CbGpPWpGaD
Gemcitabine—Anorexia—Clonidine—glaucoma	0.000586	0.00087	CcSEcCtD
Gemcitabine—Asthenia—Dorzolamide—glaucoma	0.000584	0.000867	CcSEcCtD
Gemcitabine—Asthenia—Travoprost—glaucoma	0.000582	0.000864	CcSEcCtD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—glaucoma	0.000579	0.00178	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—FGFR1OP—glaucoma	0.000576	0.00177	CbGpPWpGaD
Gemcitabine—Pruritus—Dorzolamide—glaucoma	0.000576	0.000855	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—glaucoma	0.000576	0.00176	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—CDKN1B—glaucoma	0.000575	0.00176	CbGpPWpGaD
Gemcitabine—Asthenia—Brinzolamide—glaucoma	0.000574	0.000853	CcSEcCtD
Gemcitabine—Hypotension—Clonidine—glaucoma	0.000574	0.000852	CcSEcCtD
Gemcitabine—Pruritus—Travoprost—glaucoma	0.000574	0.000852	CcSEcCtD
Gemcitabine—Cough—Betaxolol—glaucoma	0.000572	0.000849	CcSEcCtD
Gemcitabine—Nausea—Bimatoprost—glaucoma	0.000572	0.000849	CcSEcCtD
Gemcitabine—Cardiac disorder—Timolol—glaucoma	0.000571	0.000847	CcSEcCtD
Gemcitabine—Pruritus—Brinzolamide—glaucoma	0.000566	0.000841	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle—RAB8A—glaucoma	0.000566	0.00173	CbGpPWpGaD
Gemcitabine—Vomiting—Acetazolamide—glaucoma	0.000565	0.000839	CcSEcCtD
Gemcitabine—Musculoskeletal discomfort—Clonidine—glaucoma	0.00056	0.000831	CcSEcCtD
Gemcitabine—POLD1—DNA Replication—CDKN1B—glaucoma	0.000558	0.00171	CbGpPWpGaD
Gemcitabine—Angiopathy—Timolol—glaucoma	0.000558	0.000829	CcSEcCtD
Gemcitabine—Myalgia—Betaxolol—glaucoma	0.000558	0.000828	CcSEcCtD
Gemcitabine—Arthralgia—Betaxolol—glaucoma	0.000558	0.000828	CcSEcCtD
Gemcitabine—Chest pain—Betaxolol—glaucoma	0.000558	0.000828	CcSEcCtD
Gemcitabine—Diarrhoea—Dorzolamide—glaucoma	0.000557	0.000827	CcSEcCtD
Gemcitabine—Headache—Acetazolamide—glaucoma	0.000557	0.000826	CcSEcCtD
Gemcitabine—Insomnia—Clonidine—glaucoma	0.000556	0.000825	CcSEcCtD
Gemcitabine—Immune system disorder—Timolol—glaucoma	0.000556	0.000825	CcSEcCtD
Gemcitabine—Diarrhoea—Travoprost—glaucoma	0.000555	0.000824	CcSEcCtD
Gemcitabine—Mediastinal disorder—Timolol—glaucoma	0.000554	0.000823	CcSEcCtD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000554	0.000823	CcSEcCtD
Gemcitabine—CDA—Metabolism—CA2—glaucoma	0.000554	0.0017	CbGpPWpGaD
Gemcitabine—Asthenia—Pilocarpine—glaucoma	0.000552	0.00082	CcSEcCtD
Gemcitabine—Paraesthesia—Clonidine—glaucoma	0.000552	0.000819	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—glaucoma	0.000552	0.00169	CbGpPWpGaD
Gemcitabine—Discomfort—Betaxolol—glaucoma	0.000551	0.000818	CcSEcCtD
Gemcitabine—Arrhythmia—Timolol—glaucoma	0.00055	0.000816	CcSEcCtD
Gemcitabine—POLA1—Cell Cycle, Mitotic—OPTN—glaucoma	0.000549	0.00168	CbGpPWpGaD
Gemcitabine—Dyspnoea—Clonidine—glaucoma	0.000548	0.000813	CcSEcCtD
Gemcitabine—Diarrhoea—Brinzolamide—glaucoma	0.000548	0.000813	CcSEcCtD
Gemcitabine—Somnolence—Clonidine—glaucoma	0.000546	0.000811	CcSEcCtD
Gemcitabine—Pruritus—Pilocarpine—glaucoma	0.000544	0.000808	CcSEcCtD
Gemcitabine—Alopecia—Timolol—glaucoma	0.000544	0.000807	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle—RAB8A—glaucoma	0.000542	0.00166	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—CDKN1B—glaucoma	0.000541	0.00166	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—CDKN1B—glaucoma	0.000539	0.00165	CbGpPWpGaD
Gemcitabine—Rash—Brimonidine—glaucoma	0.000538	0.000798	CcSEcCtD
Gemcitabine—Dermatitis—Brimonidine—glaucoma	0.000537	0.000797	CcSEcCtD
Gemcitabine—Erythema—Timolol—glaucoma	0.000535	0.000795	CcSEcCtD
Gemcitabine—Oedema—Betaxolol—glaucoma	0.000535	0.000794	CcSEcCtD
Gemcitabine—Headache—Brimonidine—glaucoma	0.000534	0.000793	CcSEcCtD
Gemcitabine—Decreased appetite—Clonidine—glaucoma	0.000534	0.000793	CcSEcCtD
Gemcitabine—Infection—Betaxolol—glaucoma	0.000531	0.000789	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Clonidine—glaucoma	0.000531	0.000788	CcSEcCtD
Gemcitabine—Fatigue—Clonidine—glaucoma	0.00053	0.000786	CcSEcCtD
Gemcitabine—Nausea—Acetazolamide—glaucoma	0.000528	0.000783	CcSEcCtD
Gemcitabine—Diarrhoea—Pilocarpine—glaucoma	0.000526	0.000782	CcSEcCtD
Gemcitabine—TYMS—Cell Cycle, Mitotic—OPTN—glaucoma	0.000526	0.00161	CbGpPWpGaD
Gemcitabine—Pain—Clonidine—glaucoma	0.000525	0.00078	CcSEcCtD
Gemcitabine—Constipation—Clonidine—glaucoma	0.000525	0.00078	CcSEcCtD
Gemcitabine—Nervous system disorder—Betaxolol—glaucoma	0.000525	0.000779	CcSEcCtD
Gemcitabine—Thrombocytopenia—Betaxolol—glaucoma	0.000524	0.000778	CcSEcCtD
Gemcitabine—Skin disorder—Betaxolol—glaucoma	0.00052	0.000771	CcSEcCtD
Gemcitabine—POLE—G1/S Transition—CDKN1B—glaucoma	0.000519	0.00159	CbGpPWpGaD
Gemcitabine—Vomiting—Dorzolamide—glaucoma	0.000518	0.000769	CcSEcCtD
Gemcitabine—Hyperhidrosis—Betaxolol—glaucoma	0.000517	0.000768	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000515	0.00158	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—SLC6A1—glaucoma	0.000515	0.00158	CbGpPWpGaD
Gemcitabine—Rash—Dorzolamide—glaucoma	0.000513	0.000762	CcSEcCtD
Gemcitabine—Dermatitis—Dorzolamide—glaucoma	0.000513	0.000761	CcSEcCtD
Gemcitabine—Rash—Travoprost—glaucoma	0.000511	0.000759	CcSEcCtD
Gemcitabine—Dermatitis—Travoprost—glaucoma	0.000511	0.000758	CcSEcCtD
Gemcitabine—Headache—Dorzolamide—glaucoma	0.00051	0.000757	CcSEcCtD
Gemcitabine—Anorexia—Betaxolol—glaucoma	0.00051	0.000757	CcSEcCtD
Gemcitabine—POLA1—E2F transcription factor network—CDKN1B—glaucoma	0.00051	0.00156	CbGpPWpGaD
Gemcitabine—Vomiting—Brinzolamide—glaucoma	0.000509	0.000756	CcSEcCtD
Gemcitabine—Headache—Travoprost—glaucoma	0.000508	0.000754	CcSEcCtD
Gemcitabine—TYMS—Metabolism—NARFL—glaucoma	0.000507	0.00155	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CA5A—glaucoma	0.000507	0.00155	CbGpPWpGaD
Gemcitabine—Nausea—Brimonidine—glaucoma	0.000506	0.000752	CcSEcCtD
Gemcitabine—Feeling abnormal—Clonidine—glaucoma	0.000506	0.000752	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000506	0.00155	CbGpPWpGaD
Gemcitabine—Rash—Brinzolamide—glaucoma	0.000505	0.000749	CcSEcCtD
Gemcitabine—Dermatitis—Brinzolamide—glaucoma	0.000504	0.000749	CcSEcCtD
Gemcitabine—Headache—Brinzolamide—glaucoma	0.000502	0.000745	CcSEcCtD
Gemcitabine—Hypotension—Betaxolol—glaucoma	0.0005	0.000742	CcSEcCtD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000494	0.00151	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000494	0.00151	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—OPTN—glaucoma	0.000491	0.0015	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NGFR—glaucoma	0.00049	0.0015	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GSTT1—glaucoma	0.00049	0.0015	CbGpPWpGaD
Gemcitabine—Vomiting—Pilocarpine—glaucoma	0.000489	0.000726	CcSEcCtD
Gemcitabine—TYMS—E2F transcription factor network—CDKN1B—glaucoma	0.000489	0.0015	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—CDKN1B—glaucoma	0.000488	0.0015	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000487	0.000724	CcSEcCtD
Gemcitabine—Body temperature increased—Clonidine—glaucoma	0.000486	0.000721	CcSEcCtD
Gemcitabine—Rash—Pilocarpine—glaucoma	0.000485	0.00072	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000485	0.00149	CbGpPWpGaD
Gemcitabine—Dermatitis—Pilocarpine—glaucoma	0.000485	0.00072	CcSEcCtD
Gemcitabine—Insomnia—Betaxolol—glaucoma	0.000484	0.000718	CcSEcCtD
Gemcitabine—Nausea—Dorzolamide—glaucoma	0.000484	0.000718	CcSEcCtD
Gemcitabine—Headache—Pilocarpine—glaucoma	0.000482	0.000716	CcSEcCtD
Gemcitabine—Nausea—Travoprost—glaucoma	0.000482	0.000715	CcSEcCtD
Gemcitabine—Paraesthesia—Betaxolol—glaucoma	0.00048	0.000713	CcSEcCtD
Gemcitabine—Dyspnoea—Betaxolol—glaucoma	0.000477	0.000708	CcSEcCtD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—glaucoma	0.000476	0.00146	CbGpPWpGaD
Gemcitabine—Nausea—Brinzolamide—glaucoma	0.000476	0.000706	CcSEcCtD
Gemcitabine—POLE—S Phase—CDKN1B—glaucoma	0.000471	0.00144	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—OPTN—glaucoma	0.00047	0.00144	CbGpPWpGaD
Gemcitabine—Cough—Timolol—glaucoma	0.000467	0.000694	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000466	0.00143	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—NTRK1—glaucoma	0.000466	0.00143	CbGpPWpGaD
Gemcitabine—Decreased appetite—Betaxolol—glaucoma	0.000465	0.00069	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000463	0.00142	CbGpPWpGaD
Gemcitabine—Hypertension—Timolol—glaucoma	0.000462	0.000686	CcSEcCtD
Gemcitabine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000462	0.000686	CcSEcCtD
Gemcitabine—Fatigue—Betaxolol—glaucoma	0.000461	0.000685	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CA1—glaucoma	0.000459	0.00141	CbGpPWpGaD
Gemcitabine—Pain—Betaxolol—glaucoma	0.000457	0.000679	CcSEcCtD
Gemcitabine—Constipation—Betaxolol—glaucoma	0.000457	0.000679	CcSEcCtD
Gemcitabine—Nausea—Pilocarpine—glaucoma	0.000457	0.000678	CcSEcCtD
Gemcitabine—Myalgia—Timolol—glaucoma	0.000456	0.000677	CcSEcCtD
Gemcitabine—Chest pain—Timolol—glaucoma	0.000456	0.000677	CcSEcCtD
Gemcitabine—Arthralgia—Timolol—glaucoma	0.000456	0.000677	CcSEcCtD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000456	0.0014	CbGpPWpGaD
Gemcitabine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000453	0.000672	CcSEcCtD
Gemcitabine—Discomfort—Timolol—glaucoma	0.00045	0.000669	CcSEcCtD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000447	0.00137	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CTSA—glaucoma	0.000445	0.00136	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000444	0.00136	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000443	0.00136	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000443	0.00136	CbGpPWpGaD
Gemcitabine—Asthenia—Clonidine—glaucoma	0.000441	0.000654	CcSEcCtD
Gemcitabine—Feeling abnormal—Betaxolol—glaucoma	0.000441	0.000654	CcSEcCtD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000438	0.00134	CbGpPWpGaD
Gemcitabine—Oedema—Timolol—glaucoma	0.000437	0.000649	CcSEcCtD
Gemcitabine—Anaphylactic shock—Timolol—glaucoma	0.000437	0.000649	CcSEcCtD
Gemcitabine—Pruritus—Clonidine—glaucoma	0.000435	0.000645	CcSEcCtD
Gemcitabine—Infection—Timolol—glaucoma	0.000434	0.000645	CcSEcCtD
Gemcitabine—Nervous system disorder—Timolol—glaucoma	0.000429	0.000636	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—glaucoma	0.000425	0.0013	CbGpPWpGaD
Gemcitabine—Skin disorder—Timolol—glaucoma	0.000425	0.00063	CcSEcCtD
Gemcitabine—Body temperature increased—Betaxolol—glaucoma	0.000423	0.000628	CcSEcCtD
Gemcitabine—Hyperhidrosis—Timolol—glaucoma	0.000422	0.000627	CcSEcCtD
Gemcitabine—Diarrhoea—Clonidine—glaucoma	0.00042	0.000624	CcSEcCtD
Gemcitabine—RRM1—Metabolism—CA2—glaucoma	0.00042	0.00129	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000419	0.00129	CbGpPWpGaD
Gemcitabine—Anorexia—Timolol—glaucoma	0.000417	0.000618	CcSEcCtD
Gemcitabine—POLA1—Synthesis of DNA—CDKN1B—glaucoma	0.00041	0.00126	CbGpPWpGaD
Gemcitabine—Hypotension—Timolol—glaucoma	0.000408	0.000606	CcSEcCtD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000407	0.00125	CbGpPWpGaD
Gemcitabine—Musculoskeletal discomfort—Timolol—glaucoma	0.000398	0.000591	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000397	0.00122	CbGpPWpGaD
Gemcitabine—Insomnia—Timolol—glaucoma	0.000395	0.000587	CcSEcCtD
Gemcitabine—Paraesthesia—Timolol—glaucoma	0.000392	0.000583	CcSEcCtD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000391	0.0012	CbGpPWpGaD
Gemcitabine—Vomiting—Clonidine—glaucoma	0.000391	0.00058	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—ABCA1—glaucoma	0.00039	0.0012	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CYP1B1—glaucoma	0.00039	0.0012	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—TXN—glaucoma	0.00039	0.0012	CbGpPWpGaD
Gemcitabine—Dyspnoea—Timolol—glaucoma	0.00039	0.000578	CcSEcCtD
Gemcitabine—Somnolence—Timolol—glaucoma	0.000389	0.000577	CcSEcCtD
Gemcitabine—Rash—Clonidine—glaucoma	0.000387	0.000575	CcSEcCtD
Gemcitabine—Dermatitis—Clonidine—glaucoma	0.000387	0.000575	CcSEcCtD
Gemcitabine—Headache—Clonidine—glaucoma	0.000385	0.000571	CcSEcCtD
Gemcitabine—POLA1—DNA Replication—CDKN1B—glaucoma	0.000384	0.00118	CbGpPWpGaD
Gemcitabine—Asthenia—Betaxolol—glaucoma	0.000384	0.00057	CcSEcCtD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.00038	0.00117	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.00038	0.00116	CbGpPWpGaD
Gemcitabine—Decreased appetite—Timolol—glaucoma	0.00038	0.000564	CcSEcCtD
Gemcitabine—Pruritus—Betaxolol—glaucoma	0.000378	0.000562	CcSEcCtD
Gemcitabine—RRM2—Metabolism—CA1—glaucoma	0.000378	0.00116	CbGpPWpGaD
Gemcitabine—Gastrointestinal disorder—Timolol—glaucoma	0.000377	0.00056	CcSEcCtD
Gemcitabine—Fatigue—Timolol—glaucoma	0.000377	0.000559	CcSEcCtD
Gemcitabine—POLD1—Metabolism—CA1—glaucoma	0.000376	0.00115	CbGpPWpGaD
Gemcitabine—Pain—Timolol—glaucoma	0.000374	0.000555	CcSEcCtD
Gemcitabine—POLA1—G1/S Transition—CDKN1B—glaucoma	0.00037	0.00113	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CCND2—glaucoma	0.000368	0.00113	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CTSA—glaucoma	0.000366	0.00112	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CCND2—glaucoma	0.000366	0.00112	CbGpPWpGaD
Gemcitabine—Diarrhoea—Betaxolol—glaucoma	0.000366	0.000543	CcSEcCtD
Gemcitabine—Nausea—Clonidine—glaucoma	0.000365	0.000542	CcSEcCtD
Gemcitabine—TYMS—Circadian rythm related genes—FAS—glaucoma	0.000365	0.00112	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CTSA—glaucoma	0.000364	0.00111	CbGpPWpGaD
Gemcitabine—Feeling abnormal—Timolol—glaucoma	0.00036	0.000535	CcSEcCtD
Gemcitabine—TYMS—G1/S Transition—CDKN1B—glaucoma	0.000354	0.00109	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CCND2—glaucoma	0.000354	0.00108	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CA1—glaucoma	0.000353	0.00108	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000352	0.00108	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000349	0.00107	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CA2—glaucoma	0.000346	0.00106	CbGpPWpGaD
Gemcitabine—Body temperature increased—Timolol—glaucoma	0.000345	0.000513	CcSEcCtD
Gemcitabine—POLD1—Metabolism—CA2—glaucoma	0.000344	0.00105	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CTSA—glaucoma	0.000342	0.00105	CbGpPWpGaD
Gemcitabine—Vomiting—Betaxolol—glaucoma	0.00034	0.000505	CcSEcCtD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000339	0.00104	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—glaucoma	0.000337	0.00103	CbGpPWpGaD
Gemcitabine—Rash—Betaxolol—glaucoma	0.000337	0.000501	CcSEcCtD
Gemcitabine—Dermatitis—Betaxolol—glaucoma	0.000337	0.0005	CcSEcCtD
Gemcitabine—POLA1—S Phase—CDKN1B—glaucoma	0.000336	0.00103	CbGpPWpGaD
Gemcitabine—Headache—Betaxolol—glaucoma	0.000335	0.000498	CcSEcCtD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.00033	0.00101	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CCND2—glaucoma	0.000329	0.00101	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000328	0.00101	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CCND2—glaucoma	0.000327	0.001	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000325	0.000996	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CA2—glaucoma	0.000323	0.00099	CbGpPWpGaD
Gemcitabine—Nausea—Betaxolol—glaucoma	0.000318	0.000472	CcSEcCtD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000317	0.000971	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CCND2—glaucoma	0.000316	0.000969	CbGpPWpGaD
Gemcitabine—Asthenia—Timolol—glaucoma	0.000314	0.000465	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—GSTM1—glaucoma	0.000312	0.000956	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000312	0.000955	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—EDN1—glaucoma	0.00031	0.000949	CbGpPWpGaD
Gemcitabine—Pruritus—Timolol—glaucoma	0.000309	0.000459	CcSEcCtD
Gemcitabine—CDA—Metabolism—GSTT1—glaucoma	0.000303	0.000927	CbGpPWpGaD
Gemcitabine—Diarrhoea—Timolol—glaucoma	0.000299	0.000444	CcSEcCtD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000299	0.000916	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN1B—glaucoma	0.000299	0.000915	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—TXN—glaucoma	0.000296	0.000906	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2B—glaucoma	0.000295	0.000904	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2B—glaucoma	0.000293	0.000899	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	0.000284	0.00087	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2B—glaucoma	0.000283	0.000868	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000278	0.000853	CbGpPWpGaD
Gemcitabine—Vomiting—Timolol—glaucoma	0.000278	0.000413	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—MTHFR—glaucoma	0.000276	0.000845	CbGpPWpGaD
Gemcitabine—Rash—Timolol—glaucoma	0.000276	0.000409	CcSEcCtD
Gemcitabine—Dermatitis—Timolol—glaucoma	0.000275	0.000409	CcSEcCtD
Gemcitabine—Headache—Timolol—glaucoma	0.000274	0.000406	CcSEcCtD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—glaucoma	0.000267	0.000817	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—IL1A—glaucoma	0.000267	0.000817	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000264	0.000808	CbGpPWpGaD
Gemcitabine—Nausea—Timolol—glaucoma	0.00026	0.000385	CcSEcCtD
Gemcitabine—CMPK1—Metabolism—APOE—glaucoma	0.000257	0.000787	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—CAV1—glaucoma	0.000254	0.000779	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CCND2—glaucoma	0.000252	0.000772	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000249	0.000764	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CA1—glaucoma	0.000248	0.000759	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—TXN—glaucoma	0.000244	0.000746	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—TXN—glaucoma	0.000242	0.000742	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CCND2—glaucoma	0.000241	0.000739	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CYP1B1—glaucoma	0.000241	0.000739	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCA1—glaucoma	0.000241	0.000739	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CTSA—glaucoma	0.00024	0.000735	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	0.000239	0.000732	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—FAS—glaucoma	0.000238	0.000728	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000236	0.000724	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—C3—glaucoma	0.000234	0.000718	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTT1—glaucoma	0.000229	0.000703	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—TXN—glaucoma	0.000228	0.000697	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CA2—glaucoma	0.000227	0.000694	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	0.000226	0.000693	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000226	0.000692	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CCND2—glaucoma	0.000225	0.00069	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2B—glaucoma	0.000216	0.000663	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CCND2—glaucoma	0.000216	0.000661	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	0.000207	0.000635	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2B—glaucoma	0.000202	0.000619	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000201	0.000615	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000196	0.000602	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2B—glaucoma	0.000193	0.000593	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GSTM1—glaucoma	0.000193	0.000591	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—NOS3—glaucoma	0.000192	0.000589	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	0.000192	0.000588	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTT1—glaucoma	0.000189	0.000579	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000189	0.000578	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	0.000188	0.000577	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTT1—glaucoma	0.000188	0.000575	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000188	0.000575	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCA1—glaucoma	0.000183	0.00056	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CYP1B1—glaucoma	0.000183	0.00056	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000181	0.000555	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTT1—glaucoma	0.000176	0.000541	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—glaucoma	0.000176	0.000539	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MTHFR—glaucoma	0.00017	0.000522	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—glaucoma	0.000169	0.000517	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000168	0.000516	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—glaucoma	0.000168	0.000514	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000167	0.000512	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000166	0.000509	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—glaucoma	0.000162	0.000497	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	0.000161	0.000494	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.00016	0.000492	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—TXN—glaucoma	0.00016	0.000489	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—APOE—glaucoma	0.000159	0.000486	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—CAV1—glaucoma	0.000157	0.000481	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA5A—glaucoma	0.000156	0.000479	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NARFL—glaucoma	0.000156	0.000479	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCA1—glaucoma	0.00015	0.000461	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CYP1B1—glaucoma	0.00015	0.000461	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.00015	0.000458	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CYP1B1—glaucoma	0.00015	0.000458	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCA1—glaucoma	0.00015	0.000458	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN1B—glaucoma	0.00015	0.000458	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN1B—glaucoma	0.000149	0.000455	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000148	0.000455	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GSTM1—glaucoma	0.000146	0.000448	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN1B—glaucoma	0.000144	0.00044	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	0.000142	0.000436	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCA1—glaucoma	0.000141	0.000431	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CYP1B1—glaucoma	0.000141	0.000431	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000138	0.000422	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000137	0.00042	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—glaucoma	0.000137	0.000418	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	0.000136	0.000416	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000129	0.000396	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MTHFR—glaucoma	0.000129	0.000396	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	0.000128	0.000392	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTT1—glaucoma	0.000124	0.000379	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—glaucoma	0.000124	0.000379	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GSTM1—glaucoma	0.00012	0.000369	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—APOE—glaucoma	0.00012	0.000368	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GSTM1—glaucoma	0.00012	0.000366	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—CAV1—glaucoma	0.000119	0.000365	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—NOS3—glaucoma	0.000119	0.000364	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—VEGFA—glaucoma	0.000118	0.000361	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000117	0.000359	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—glaucoma	0.000115	0.000354	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.000114	0.00035	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GSTM1—glaucoma	0.000112	0.000344	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—glaucoma	0.000111	0.000339	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN1B—glaucoma	0.00011	0.000336	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—glaucoma	0.000109	0.000333	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MTHFR—glaucoma	0.000106	0.000326	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MTHFR—glaucoma	0.000106	0.000324	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN1B—glaucoma	0.000102	0.000313	CbGpPWpGaD
Gemcitabine—ABCB1—Allograft Rejection—TNF—glaucoma	0.000101	0.000309	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.0001	0.000307	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MTHFR—glaucoma	9.93e-05	0.000304	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—APOE—glaucoma	9.9e-05	0.000303	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CYP1B1—glaucoma	9.86e-05	0.000302	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCA1—glaucoma	9.86e-05	0.000302	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—APOE—glaucoma	9.84e-05	0.000301	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—CAV1—glaucoma	9.81e-05	0.0003	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN1B—glaucoma	9.8e-05	0.0003	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—CAV1—glaucoma	9.75e-05	0.000299	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—glaucoma	9.39e-05	0.000288	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	9.37e-05	0.000287	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—glaucoma	9.34e-05	0.000286	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—APOE—glaucoma	9.25e-05	0.000283	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—CAV1—glaucoma	9.16e-05	0.000281	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—glaucoma	9.02e-05	0.000276	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—NOS3—glaucoma	9e-05	0.000276	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—glaucoma	8.24e-05	0.000252	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GSTM1—glaucoma	7.88e-05	0.000242	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA1—glaucoma	7.64e-05	0.000234	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—NOS3—glaucoma	7.41e-05	0.000227	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CTSA—glaucoma	7.4e-05	0.000227	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.37e-05	0.000226	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—NOS3—glaucoma	7.37e-05	0.000226	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CA2—glaucoma	6.99e-05	0.000214	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.98e-05	0.000214	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MTHFR—glaucoma	6.97e-05	0.000213	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—NOS3—glaucoma	6.93e-05	0.000212	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—glaucoma	6.78e-05	0.000208	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—glaucoma	6.74e-05	0.000207	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—APOE—glaucoma	6.49e-05	0.000199	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—glaucoma	6.43e-05	0.000197	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—CAV1—glaucoma	6.43e-05	0.000197	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—glaucoma	6.34e-05	0.000194	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—glaucoma	6.16e-05	0.000189	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.81e-05	0.000178	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.98e-05	0.000153	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—TXN—glaucoma	4.92e-05	0.000151	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—NOS3—glaucoma	4.86e-05	0.000149	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—glaucoma	4.44e-05	0.000136	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.39e-05	0.000134	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTT1—glaucoma	3.82e-05	0.000117	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—ABCA1—glaucoma	3.04e-05	9.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CYP1B1—glaucoma	3.04e-05	9.32e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GSTM1—glaucoma	2.43e-05	7.45e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MTHFR—glaucoma	2.15e-05	6.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—APOE—glaucoma	2e-05	6.13e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—CAV1—glaucoma	1.98e-05	6.08e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—NOS3—glaucoma	1.5e-05	4.59e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—glaucoma	1.37e-05	4.2e-05	CbGpPWpGaD
